Company intelligence / Profile preview

Paragon 28

Englewood, Colorado, United Statesparagon28.com ↗

Ownership: Public · FNA
Employees: ~525
Development stage: Commercial

Overview

Paragon 28 has developed nearly 80 commercialized product systems for the surgical management of complex and routine foot and ankle disorders. The company’s portfolio includes plates, screws, staples, nails, advanced joint/bone replacements, orthobiologics adjuncts, and specialized instruments. Their solutions address fracture fixation as well as reconstructive needs for progressive deformities such as PCFD/flatfoot or Charcot neuroarthropathy. The company was acquired by Zimmer Biomet in April 2025 to strengthen that company's presence in the high-growth global foot and ankle segment.

Therapeutic areas: OtherEndocrinologyRheumatology
Modalities: DeviceSurgical implantOrthobiologicsSurgical instrumentation
Industry: Implantable Medical Devices

Partnerships

Processed biologics supplied by VIVEX Biologics for some orthobiologic productsnow integrated with Zimmer Biomet's distribution network post-acquisition.

Financials

Market cap: $1.1B
Total revenue: $71.7M
Enterprise value: $1.2B

Beyond the preview

Go deeper on Paragon 28.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paragon 28.

Explore the full profile